Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
Julie Galloway Mabeus Joins HDA as Director of Policy
The Healthcare Distribution Alliance (HDA) announces Julie Galloway Mabeus as its new Director of Policy.
HDA Announces Government Affairs and Policy Staffing Updates
The Healthcare Distribution Alliance (HDA) announces updates regarding staff leading its Government Affairs and Policy teams.
HDA Statement on Drug Shortages
Healthcare Distribution Alliance (HDA) President and CEO Chip Davis released the following statement in response to the Senate Finance Committee hearing entitled, “Drug Shortages: Examining Supply Challenges, Impacts, and Policy Solutions from a Federal Health Program Perspective.”
Health Delivered: Reaffirming Distributors' Fundamental Value to U.S. Healthcare
For the past year, I have watched the men and women of the healthcare distribution industry go above and beyond on a daily basis to make sure medicines, vaccines, PPE and other medical supplies reached patients and providers across the country. Their energy, determination and commitment have ensured a resilient supply chain during the most challenging days of the COVID-19 pandemic and a distribution network that has continued to deliver value each and every day.
HDA Statement on Senate Confirmation of Dr. Marty Makary As FDA Commissioner
The Healthcare Distribution Alliance (HDA) released the following statement on the U.S. Senate’s vote to confirm Dr. Marty Makary as the Food and Drug Administration (FDA) Commissioner.